Stephen A. Hill, Director at Cellectar Biosciences, Inc. (CLRB), bought 18,000 shares at $1.08 ($19K) on 2020-06-04, disclosed to the SEC on 2020-06-08.
Open-market purchase of $19k CLRB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| CLRB | BUY | 2016-04-21 | $20K | — | Filing → |
| CBIO | BUY | 2015-12-18 | $10K | — | Filing → |
| LPCN | BUY | 2014-11-13 | $20K | — | Filing → |